SCHEMBL606847

SCHEMBL606847

CC[N+](CC)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3779898 0.69
SCHEMBL7490993 0.69
SCHEMBL11198716 0.65 ALDH1A1 (0.39)
Trimethylammonium SCHEMBL9185431 0.55 ALDH1A1 (0.30)
Trimethylammonium SCHEMBL160656 0.55
N,N-Dimethylethanaminium SCHEMBL16338 0.51
N,N-Dimethylethanaminium SCHEMBL2146567 0.51 TSHR (0.36)
SCHEMBL98977 0.51
SCHEMBL352063 0.51
N,N-Dimethylethanaminium SCHEMBL352062 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380883-B Aminoalkoxy tripterine derivative, preparation method and application 中国人民解放军空军军医大学 2023-06-30 CN claimed
EP-0138464-B1 2-AMINO-5-HYDROXY-4-METHYLPYRIMIDINE DERIVATIVES PFIZER INC. (US) 1989-11-15 EP claimed
EP-0222253-B1 SUBSTITUTED 5-AMINO-1-ARYL-PYRAZOLES BAYER AG (DE) 1989-04-05 EP claimed
US-4725677-A USING PHOSPHINE DERIVATIVE BIOSYNTECH GMBH (DE) 1988-02-16 US claimed
EP-0137351-A2 Process for the enantioselective préparation of acyclic alpha-alkylated alpha-aminecarboxylic acids Degussa Aktiengesellschaft (DE) 1985-04-17 EP claimed
CN-114380883-B Aminoalkoxy tripterine derivative, preparation method and application 中国人民解放军空军军医大学 2023-06-30 CN disclosed
EP-3851444-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR Oric Pharmaceuticals, Inc. (US) 2021-07-21 EP disclosed
US-20210128561-A1 MRGX Receptor Antagonists KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2021-05-06 US disclosed
US-10093657-B2 Inhibitors of bruton's tyrosine kinase HOFFMANN-LA ROCHE INC. (US) 2018-10-09 US disclosed
US-20170183327-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE CHUGAI PHARMACEUTICAL CO. (JP) 2017-06-29 US disclosed
US-20160361356-A1 METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR ENHANCING SURVIVABILITY OF CELLS, TISSUES, ORGANS, AND ORGANISMS FRED HUTCHINSON CANCER RESEARCH CENTER 2016-12-15 US disclosed
US-8822535-B2 Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2014-09-02 US disclosed
EP-0138464-B1 2-AMINO-5-HYDROXY-4-METHYLPYRIMIDINE DERIVATIVES PFIZER INC. (US) 1989-11-15 EP disclosed
EP-0304190-A1 (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-02-22 EP disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed
EP-0286242-A2 Ethanolamine derivates, processes for their preparation and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1988-10-12 EP disclosed
US-4767769-A HISTAMINE-H2 ANTAGONISTS THE BOOTS COMPANY PLC (GB) 1988-08-30 US disclosed
EP-0112524-B1 TRICHLOROACRYLOYL OXIME DERIVATIVES NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-05-28 EP disclosed
EP-0112524-A1 Trichloroacryloyl oxime derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1984-07-04 EP disclosed
EP-0097072-A1 Derivatives of benzylsulfinyl acetamides, their therapeutic use and process for their preparation LABORATOIRE L. LAFON Société anonyme dite: (FR) 1983-12-28 EP disclosed